A Question‐Based Approach to Adopting Pharmacogenetics to Understand Risk for Clinical Variability in Pharmacokinetics in Early Drug Development

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|3|291-295

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.3, 2014-09, pp. : 291-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges and opportunities of pharmacogenetics in drug development

By March Ruth  

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 195-206

Future Medicine

Access to resources Recommend Favorite

Translational pharmacogenetics and risk management in the cardiovascular arena: CYP3A5*3 model for gene-based drug selection

By Wilke Russell A  

Personalized Medicine, Vol. 3, Iss. 4, 2006-11 ,pp. : 385-390

Future Medicine

Access to resources Recommend Favorite

Network‐Based Approaches in Drug Discovery and Early Development

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. : 651-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 6, 2013-06 ,pp. : 502-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Pharmacogenetics in Rational Development and Personalization of Drug Treatments

By Marsh Sharon  

Personalized Medicine, Vol. 2, Iss. 1, 2005-02 ,pp. : 13-14

Future Medicine

Access to resources Recommend Favorite